Dr. Reddys Laboratories Ltd.

Dr.Reddys Laboratories has informed that the Company has filed its unaudited condensed consolidated interim financial statements prepared under IFRS in Form 6-K for the quarter ended December 31, 2018, with the United States Securities and Exchange Commission on February 1, 2019. A copy of the Form 6-K is been attached.

The above information is a part of company’s filings submitted to BSE.